Loading...
•
Dec 31, 2019
Stryker Q4 2019 Earnings Report
Stryker's Q4 2019 performance showcased strong growth, with net sales increasing and adjusted EPS exceeding guidance.
Key Takeaways
Stryker reported an 8.8% increase in net sales, reaching $4.1 billion, and an 8.0% rise in organic net sales for Q4 2019. The adjusted EPS increased by 14.2% to $2.49, surpassing the high end of the guidance range. The company's performance was driven by growth across all business segments and geographies, contributing to an excellent finish to the year.
Net sales increased by 8.8% to $4.1 billion.
Organic net sales grew by 8.0%.
Adjusted operating income margin expanded by 80 bps to 28.3%.
Adjusted EPS increased by 14.2% to $2.49, exceeding guidance.
Revenue by Segment
Forward Guidance
Stryker anticipates organic net sales growth to be between 6.5% and 7.5% in 2020, with adjusted net earnings per diluted share expected to range from $9.00 to $9.20. For the first quarter of 2020, the company projects adjusted net earnings per diluted share to be in the range of $2.05 to $2.10.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...